Literature DB >> 8275231

Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells.

C Caillaud1, S Akli, E Vigne, A Koulakoff, M Perricaudet, L Poenaru, A Kahn, Y Berwald-Netter.   

Abstract

Previous studies have demonstrated that a defective recombinant adenovirus can infect a wide range of postmitotic and slowly proliferating cell types such as hepatocytes, myotubes, pneumocytes and intestinal cells (Stratford-Perricaudet et al., Hum. Gene Ther., 1, 241-256, 1990; Quantin et al., Proc. Natl. Acad. Sci. USA, 89, 2581-2584, 1992; Jaffe et al., Nature Genetics, 1, 372-378, 1992). We have used a defective recombinant adenovirus, Ad.RSV beta gal, containing the Escherichia coli beta-galactosidase gene targeted to the nucleus under the transcriptional control of the Rous sarcoma virus long terminal repeat promoter (Stratford-Perricaudet et al., J. Clin. Invest., 90, 626-630, 1992) to infect non-dividing neural cells in primary culture. We show that 80-100% of neuronal and astroglial cells infected with a viral titre lower than 10(9) p.f.u./ml express beta-galactosidase for at least 1 month without cell damage. These results demonstrate the potential usefulness of recombinant adenovirus infection for the analysis of brain-specific gene regulation and for the transfer of genes into neural cells before their transplantation into the brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8275231     DOI: 10.1111/j.1460-9568.1993.tb00914.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  9 in total

1.  Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system.

Authors:  R L Smith; D L Traul; J Schaack; G H Clayton; K J Staley; C L Wilcox
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

3.  Gene delivery into neuronal and glial cells by using a replication-deficient adenovirus vector: prospects for neurological gene therapy.

Authors:  S Sivasubramaniam; A Fooks; J Lee; G Stacey; A Jennings
Journal:  Cytotechnology       Date:  1997-09       Impact factor: 2.058

4.  Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice.

Authors:  M Korte; O Griesbeck; C Gravel; P Carroll; V Staiger; H Thoenen; T Bonhoeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Phenotypic alteration of astrocytes induced by ciliary neurotrophic factor in the intact adult brain, As revealed by adenovirus-mediated gene transfer.

Authors:  F Lisovoski; S Akli; E Peltekian; E Vigne; G Haase; M Perricaudet; P A Dreyfus; A Kahn; M Peschanski
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

6.  Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.

Authors:  Vincent Mittoux; Stephane Ouary; Christelle Monville; Fabrice Lisovoski; Thomas Poyot; Francoise Conde; Carole Escartin; Regine Robichon; Emmanuel Brouillet; Marc Peschanski; Philippe Hantraye
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

7.  Regulation of excitatory transmission at hippocampal synapses by calbindin D28k.

Authors:  P S Chard; J Jordán; C J Marcuccilli; R J Miller; J M Leiden; R P Roos; G D Ghadge
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Lack of evidence of phenotypic complementation of E1A/E1B-deleted adenovirus type 5 upon superinfection by wild-type virus in the cotton rat.

Authors:  W Oualikene; P Gonin; M Eloit
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy.

Authors:  J F Zhang; C Hu; Y Geng; J Selm; S B Klein; A Orazi; M W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.